This page shows you your search results in order of relevance. This is page number 12.

Order by Relevance | Date

Total 5148657 results found since Jan 2013.

Reliability and Validity of the DYMUS Questionnaire for the assessment of dysphagia in Multiple Sclerosis (Greek version) and proposed modification
Conclusions The Greek version of DYMUS was found to be a valid, reliable and practical for clinical use questionnaire for the detection of dysphagia in Multiple Sclerosis. The first reported normative data for DYMUS suggest a cut-off for the diagnosis of dysphagia at 2 and our findings support a modification of DYMUS eliminating the question about weight loss.
Source: Multiple Sclerosis and Related Disorders - May 15, 2018 Category: Neurology Source Type: research

Validating the Portal Population of the United Kingdom Multiple Sclerosis Register
Publication date: Available online 25 May 2018 Source:Multiple Sclerosis and Related Disorders Author(s): RM Middleton, WJ Rodgers, J Chataway, K Schmierer, D Rog, I Galea, A Akbari, K Tuite-Dalton, H Lockhart-Jones, D Griffiths, DG Noble, KH Jones, A Al-Din, M Craner, N Evangelou, P Harman, T Harrower, J Hobart, H Husseyin, M Kasti, C Kipps, G McDonnell, C Owen, O Pearson, W Rashid, H Wilson, DV Ford The UK Multiple Sclerosis Register (UKMSR) is a large cohort study designed to capture ‘real world’ information about living with multiple sclerosis (MS) in the UK from diverse sources. The primary source of data is dire...
Source: Multiple Sclerosis and Related Disorders - May 25, 2018 Category: Neurology Source Type: research

Validating the portal population of the United Kingdom Multiple Sclerosis Register
Publication date: August 2018Source: Multiple Sclerosis and Related Disorders, Volume 24Author(s): R.M. Middleton, W.J. Rodgers, J. Chataway, K. Schmierer, D. Rog, I. Galea, A. Akbari, K. Tuite-Dalton, H. Lockhart-Jones, D. Griffiths, D.G. Noble, K.H. Jones, A. Al-Din, M. Craner, N. Evangelou, P. Harman, T. Harrower, J. Hobart, H. Husseyin, M. KastiAbstractThe UK Multiple Sclerosis Register (UKMSR) is a large cohort study designed to capture ‘real world’ information about living with multiple sclerosis (MS) in the UK from diverse sources. The primary source of data is directly from people with Multiple Sclerosis (pwMS)...
Source: Multiple Sclerosis and Related Disorders - July 5, 2018 Category: Neurology Source Type: research

Reliability and validity of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis (Greek version) and proposed modification
ConclusionsThe Greek version of DYMUS was found to be a valid, reliable and practical for clinical use questionnaire for the detection of dysphagia in Multiple Sclerosis. The first reported normative data for DYMUS suggest a cut-off for the diagnosis of dysphagia at 2 and our findings support a modification of DYMUS eliminating the question about weight loss.
Source: Multiple Sclerosis and Related Disorders - July 5, 2018 Category: Neurology Source Type: research

Validating the portal population of the United Kingdom Multiple Sclerosis Register
Publication date: August 2018Source: Multiple Sclerosis and Related Disorders, Volume 24Author(s): R.M. Middleton, W.J. Rodgers, J. Chataway, K. Schmierer, D. Rog, I. Galea, A. Akbari, K. Tuite-Dalton, H. Lockhart-Jones, D. Griffiths, D.G. Noble, K.H. Jones, A. Al-Din, M. Craner, N. Evangelou, P. Harman, T. Harrower, J. Hobart, H. Husseyin, M. KastiAbstractThe UK Multiple Sclerosis Register (UKMSR) is a large cohort study designed to capture ‘real world’ information about living with multiple sclerosis (MS) in the UK from diverse sources. The primary source of data is directly from people with Multiple Sclerosis (pwMS)...
Source: Multiple Sclerosis and Related Disorders - July 10, 2018 Category: Neurology Source Type: research

Reliability and validity of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis (Greek version) and proposed modification
ConclusionsThe Greek version of DYMUS was found to be a valid, reliable and practical for clinical use questionnaire for the detection of dysphagia in Multiple Sclerosis. The first reported normative data for DYMUS suggest a cut-off for the diagnosis of dysphagia at 2 and our findings support a modification of DYMUS eliminating the question about weight loss.
Source: Multiple Sclerosis and Related Disorders - July 10, 2018 Category: Neurology Source Type: research

Multiple sclerosis and cancer incidence: A Danish nationwide cohort study
ConclusionIn this nationwide study, multiple sclerosis patients did not have increased cancer incidence or increased cancer-specific mortality. We observed an increased risk of malignant melanoma mainly attributed to increased risk in the first part of our study period.
Source: Multiple Sclerosis and Related Disorders - December 15, 2018 Category: Neurology Source Type: research

OCD and Multiple Sclerosis
Obsessive-compulsive disorder is a complicated illness, and the cause, or causes, remain unknown. Research has shown that OCD is seen more frequently than usual in those with various physical disorders, such as muscular dystrophy. An October 2018 study published in Frontiers in Immunology highlights a connection between OCD and another disease — multiple sclerosis. Multiple sclerosis (MS) is a debilitating autoimmune disorder, where the body’s immune system goes haywire and attacks healthy cells. It affects over two million people worldwide and has no known cure. Patients with multiple sclerosis and other autoimmun...
Source: World of Psychology - December 15, 2018 Category: Psychiatry & Psychology Authors: Janet Singer Tags: Health-related OCD Research Compulsions Multiple Sclerosis Obsessions Obsessive Compulsive Disorder Source Type: blogs

Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: randomized, double-blind, placebo-controlled clinical trial. Preliminary report.
Conclusions4-aminopyridine proved to be an effective treatment on cognitive aspects in patients with relapsing-remitting multiple sclerosis. Drug doses were shown to be safe with mild to moderate adverse events. (ClinicalTrials.gov number, NCT02280096).
Source: Multiple Sclerosis and Related Disorders - December 19, 2018 Category: Neurology Source Type: research

Recurrent atrial fibrillation after pulse corticosteroid treatment for a relapse of multiple sclerosis
Publication date: Available online 23 April 2019Source: Multiple Sclerosis and Related DisordersAuthor(s): Tin Pavičić, Berislav Ruška, Ivan Adamec, Mario HabekAbstractStandard therapy for a relapse of multiple sclerosis is a high dose pulse corticosteroid therapy. Cardiovascular adverse events ranging from palpitations to serious arrhythmias like atrial fibrillation and ventricular tachycardia have been associated with this treatment. The underlying mechanism behind the development of atrial fibrillation and treatment of multiple sclerosis relapse with steroids is still unclear. In this case, a 27-year-old male with mu...
Source: Multiple Sclerosis and Related Disorders - April 23, 2019 Category: Neurology Source Type: research

Impairments of humour comprehension in multiple sclerosis
ConclusionThese preliminary results suggest that a high proportion of relapsing-remitting multiple sclerosis patients may be impaired in humour comprehension, some as a primary deficit and others as a secondary deficit to more general comprehension difficulties. On a theoretical level, the dissociations obtained between verbal and visual material do not support an amodal humour comprehension model.
Source: Multiple Sclerosis and Related Disorders - October 15, 2019 Category: Neurology Source Type: research

CSF-resident CD4+ T-cells display a distinct gene expression profile relevant to multiple sclerosis
Conclusion We report numerous gene expression differences between CSF and blood CD4+ T-cells. Identi- fied genes have relevance to multiple sclerosis pathogenesis and could contain novel treatment targets. james.hrastelj@gmail.com
Source: Journal of Neurology, Neurosurgery and Psychiatry - May 27, 2022 Category: Neurosurgery Authors: Hrastelj, J., Andrews, R., Loveless, S., Morgan, J., Bishop, M., Bray, N., Williams, N., Robertson, N. Tags: Multiple Sclerosis: 04 Source Type: research

Cells with Backpacks to Treat Multiple Sclerosis
Researchers at the Harvard Wyss Institute have developed a new type of cell therapy for multiple sclerosis patients. The technique involves taking a blood sample from the patient being treated, isolating a sample of myeloid white blood cells, and the...
Source: Medgadget - May 2, 2023 Category: Medical Devices Authors: Conn Hastings Tags: Medicine MS multiple sclerosis wyssinstitute Source Type: blogs

Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg)
Conclusion: There is no evidence for an increasing women-to-men ratio with time amongst Swedish multiple sclerosis patients.
Source: Multiple Sclerosis - January 9, 2013 Category: Neurology Authors: Bostrom, I., Stawiarz, L., Landtblom, A.-M. Tags: Research Papers Source Type: research

Multiple Sclerosis Foundation Brighter Tomorrow Grant
Each year the Multiple Sclerosis Foundation makes dreams come true for individuals with multiple sclerosis across the country through the Brighter Tomorrow grant. The goal of the grant is provide individuals with MS with goods or services (valued at up to $1000.00 per recipient) to improve their quality of life by enhancing safety, self-sufficiency, comfort, or well-being. Recipients of the Multiple Sclerosis Foundation's Brighter Tomorrow grant have received appliances, televisions, furniture, hobby supplies, retreats, and various home modifications. To qualify, a person must be 18 years of age or older and d...
Source: ScanGrants feed - January 31, 2013 Category: Research Authors: Multiple Sclerosis Foundation Source Type: funding